Home
Placeholder for missing image of Elisabeth Åvall Lundqvist

Elisabeth Åvall Lundqvist

Professor Emerita

Professor of Clinical Oncology focusing gynecological oncology

Gynaecological Cancer

My research interest is cervical cancer and how we can extend the survival rate through more effective treatments but without paying the price in the form of unwanted side effects

Research Co-operation

CABSOE

  • Prof Gillian Thomas, Toronto and Linköpings University
  • Prof Preben Kjölhede, Linköpings University
  • Elisabet Classon, PhD, Linköpings University

STROVA

  • Sara Corvigno, PhD student, Karolinska Institutet
  • Hanna Dahlstrand, main supervisor, Karolinska Institutet
  • Arne Östman, co-supervisor, Karolinska Institutet

RASHEC

  • Sara Salehi, PhD student, Karolinska Institutet
  • Henrik Falconer, main supervisor, Karolinska Institutet

2025

Diana Zach, Pernille T. Jensen, Henrik Falconer, Zuzana Kolkova, Katja Stenstroem Bohlin, Preben Kjölhede, Ivette Raices Cruz, Elisabeth Åvall Lundqvist, Angelique Floeter Radestad (2025) The impact of local symptoms on health-related quality of life in vulvar cancer survivors-A nationwide prospective study Acta Obstetricia et Gynecologica Scandinavica (Article in journal) Continue to DOI
Maria Bjurberg, Kristina Hellman, Tim A. Sall, Christian Staf, Christer Borgfeldt, Erik Holmberg, Jenny Jonsson, Gabriel Lindahl, Angelique Floter Radestad, Camilla Skold, Katja Stenstroem Bohlin, Karin Stalberg, Elisabeth Åvall Lundqvist, Preben Kjölhede, Pernilla Dahm-Kahler (2025) Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer-a Swedish gynecologic cancer group (Swe-GCG) study Acta Obstetricia et Gynecologica Scandinavica (Article in journal) Continue to DOI
Alana Brown, Laura Gravelsins, Nicole J. Gervais, Jenny Rieck, Sophia Zhao, Annie Duchesne, Suzanne T. Witt, Robin Kämpe, Rosanna Olsen, Morgan Barense, Elisabet Classon, Elvar Theodorsson, Jan Ernerudh, Elisabeth Åvall Lundqvist, Preben Kjölhede, Maria Engström, Zhuo Shao, Marcus Bernardini, Michelle Jacobson, M. Natasha Rajah, Cheryl Grady, Gillian Einstein (2025) Early midlife ovarian removal is associated with lower posterior hippocampal function Alzheimer's & Dementia: Journal of the Alzheimer's Association, Vol. 21, Article e14447 (Article in journal) Continue to DOI

2024

Suzanne T. Witt, Alana Brown, Laura Gravelsins, Maria Engström, Elisabet Classon, Nina Lykke, Elisabeth Åvall Lundqvist, Elvar Theodorsson, Jan Ernerudh, Preben Kjölhede, Gillian Einstein (2024) Gray matter volume in women with the BRCA mutation with and without ovarian removal: evidence for increased risk of late-life Alzheimer's disease or dementia Menopause: The Journal of the North American Menopause, Vol. 31, p. 608-616 (Article in journal) Continue to DOI
Kristina Engvall, Hanna Uvdal, Niclas Björn, Elisabeth Åvall Lundqvist, Henrik Green (2024) Prediction models of persistent taxane-induced peripheral neuropathy among breast cancer survivors using whole-exome sequencing npj Precision Oncology, Vol. 8, Article 102 (Article in journal) Continue to DOI
Henrik Green.

Nerve damage from cancer treatment can be predicted

Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at LiU have developed a tool that can predict the risk level for each individual.

Tags